视神经脊髓炎临床试验招募信息（全球在招）
这里汇总了全球正在招募患者的 视神经脊髓炎（国际通用名 neuromyelitis optica）新药临床试验，包含试验分期、招募状态、开展国家和研究团队联系方式，全部以中文呈现。数据实时来自全球最大的临床试验注册库 ClinicalTrials.gov。本页同时覆盖NMO、德维克病等说法。
正在招募的视神经脊髓炎新药试验
French Registry for Monitoring Pregnancies for Multiple Sclerosis
不适用招募中法国MartiniqueNCT03900221Efgartigimod for the Treatment of Acute Optic Neuritis
II 期招募中美国NCT06453694The Safety and Efficacy of NouvSoma001 in Neuromyelitis Optica Spectrum Disorders
I 期招募中中国NCT06620809Integrating Metabolism, Connectivity, and Mesoscale Imaging at Ultra-high Field to Decipher Mechanisms of Resilience and Neurodegeneration in Neurological Diseases and Healthy Aging
不适用招募中法国NCT07202494Azathioprine in MOGAD
III 期招募中法国NCT05349006Modified Zipper Therapy for AQP4-IgG Positive Neuromyelitis Optica Spectrum Disorder
III 期招募中中国NCT07420296Impact of a Structured Wellness Behavioral Intervention on Quality of Life in NMOSD
不适用招募中美国NCT06780709MS-ResearchBiomarkerS
不适用招募中美国NCT05204459China National Registry of Neuro-Inflammatory Diseases
不适用招募中中国NCT05154370Clinical Impact Through AI-assisted MS Care - A Retrospective Multi-center Observational Study.
不适用招募中Czechia德国NCT06280755Sun Yat-Sen Cohort of CNS Idiopathic Inflammatory Demyelinating Diseases
不适用招募中中国NCT06541626Observational Safety Study in Women With Neuromyelitis Optica Spectrum Disorder (NMOSD) Exposed to UPLIZNA® During Pregnancy
不适用招募中美国NCT05909761
视神经脊髓炎试验不在中国大陆，还能参加吗？
可以尝试四条现实路径：查找国内同类试验、申请同情用药与扩展准入、赴境外研究中心入组、直接写信给申办方申请在华开展。本站提供中英文对照的咨询信模板，患者和家属填写基本情况即可生成。